Untreated Childhood Acute Lymphoblastic Leukemia: Clinical Trials

13 trials for Untreated Childhood Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 1 withdrawn. 7 Phase 2, 4 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 14Completed 4
Not applicable2Completed 2

Follow Untreated Childhood Acute Lymphoblastic Leukemia: new trials by email Literature Review of Untreated Childhood Acute Lymphoblastic Leukemia trials Research Report on Untreated Childhood Acute Lymphoblastic Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
laboratory biomarker analysis - B-cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
CompletedChildren's Oncology Group402012-06-012016-05-18
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
treosulfan, fludarabine phosphate, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center962009-02-012021-06-22
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
nilotinib, imatinib mesylate, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center402008-08-142017-08-10
Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
Daunorubicin Hydrochloride, Pharmacological Study, Prednisolone - Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
WithdrawnChildren's Oncology Group2008-03-242018-08-07
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Cognitive Assessment, Diffusion Tensor Imaging, Laboratory Biomarker Analysis - Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia
CompletedChildren's Oncology Group2332007-01-012017-07-21
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
doxorubicin hydrochloride, cyclophosphamide, methotrexate - Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma
Phase 2CompletedChildren's Oncology Group972004-06-012014-09-19
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
fludarabine phosphate, total-body irradiation, mycophenolate mofetil - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center1502004-04-012020-01-29
Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
laboratory biomarker analysis - Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
CompletedChildren's Oncology Group111962003-12-012023-08-03
Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center372003-09-012020-01-18
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
allopurinol, cyclophosphamide, daunorubicin hydrochloride - Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)3022003-06-012022-05-03
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Fludarabine Phosphate, Total-Body Irradiation, Peripheral Blood Stem Cell Transplantation - Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center1062001-08-012019-12-20
Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
prednisone, vincristine sulfate, daunorubicin hydrochloride - T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
Not applicableCompletedNational Cancer Institute (NCI)1002001-04-012013-01-16
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia
Not applicableCompletedFred Hutchinson Cancer Center1602000-12-012020-01-21

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (9)  ·  Leukemia, Myeloid, Acute (5)  ·  Burkitt Lymphoma (4)  ·  Congenital Abnormalities (4)  ·  Dendritic Cell Sarcoma, Interdigitating (4)  ·  Hodgkin Disease (4)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (4)  ·  Leukemia, Myeloid, Accelerated Phase (4)  ·  Leukemia, Myelomonocytic, Chronic (4)  ·  Lymphoma, Large B-Cell, Diffuse (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Blast Crisis (3)  ·  Immunoblastic Lymphadenopathy (3)  ·  Leukemia, Hairy Cell (3)  ·  Leukemia, Myeloid, Chronic-Phase (3)

Broader conditions

Hemic and Lymphatic Diseases (10)  ·  Immune System Diseases (10)  ·  Immunoproliferative Disorders (10)  ·  Lymphatic Diseases (10)  ·  Lymphoproliferative Disorders (10)  ·  Neoplasms (10)  ·  Neoplasms by Histologic Type (10)  ·  Hematologic Diseases (9)  ·  Leukemia (9)  ·  Leukemia, Lymphoid (9)  ·  Bone Marrow Diseases (6)  ·  Chronic Disease (6)  ·  Disease Attributes (6)  ·  Leukemia, Myeloid (6)  ·  Pathologic Processes (6)

Interventions

Peripheral Blood Stem Cell Transplantation (5)  ·  Whole-Body Irradiation (5)  ·  fludarabine phosphate (5)  ·  Methotrexate (4)  ·  Mycophenolic Acid (4)  ·  Vincristine (4)  ·  Cyclophosphamide (3)  ·  Cyclosporine (3)  ·  Cytarabine (3)  ·  Daunorubicin (3)  ·  Leucovorin (3)  ·  Prednisone (3)  ·  merphos (3)  ·  Asparaginase (2)  ·  Dexamethasone (2)

Sponsors

Fred Hutchinson Cancer Center (6)  ·  Children's Oncology Group (5)  ·  National Cancer Institute (NCI) (2)

Countries

United States (13)  ·  Italy (4)  ·  Germany (3)  ·  Australia (2)  ·  Canada (2)  ·  New Zealand (2)  ·  Puerto Rico (1)  ·  Switzerland (1)

Top investigators

Brenda Sandmaier (2)  ·  David Maloney (2)  ·  Boglarka Gyurkocza (1)  ·  Ian Pollack (1)  ·  Kimberly Dunsmore (1)  ·  Mignon Loh, MD (1)  ·  Mitchell Cairo, MD CCRP (1)  ·  Naomi Winick (1)  ·  Paul Carpenter (1)  ·  Wendy Stock (1)  ·  William Carroll, MD (1)

Results publications

PMID 32499241, PMID 30117142, PMID 30742559

NIH funding

P30CA015704 (5), U10CA098543 (4), P01CA018029 (3), P01CA078902 (1), P01HL036444 (1), U10CA031946 (1), U10CA095861 (1)